CN100486651C - 多器官功能支持系统 - Google Patents
多器官功能支持系统 Download PDFInfo
- Publication number
- CN100486651C CN100486651C CNB200710078431XA CN200710078431A CN100486651C CN 100486651 C CN100486651 C CN 100486651C CN B200710078431X A CNB200710078431X A CN B200710078431XA CN 200710078431 A CN200710078431 A CN 200710078431A CN 100486651 C CN100486651 C CN 100486651C
- Authority
- CN
- China
- Prior art keywords
- blood
- filter
- film
- pipeline
- pipe
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000008383 multiple organ dysfunction Effects 0.000 title claims description 18
- 239000008280 blood Substances 0.000 claims abstract description 167
- 210000004369 blood Anatomy 0.000 claims abstract description 165
- 210000004072 lung Anatomy 0.000 claims abstract description 53
- 239000012528 membrane Substances 0.000 claims abstract description 42
- 230000002572 peristaltic effect Effects 0.000 claims description 61
- 210000003462 vein Anatomy 0.000 claims description 34
- 239000002699 waste material Substances 0.000 claims description 29
- 239000012530 fluid Substances 0.000 claims description 25
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 20
- 229910052799 carbon Inorganic materials 0.000 claims description 20
- 150000001450 anions Chemical class 0.000 claims description 17
- 230000008676 import Effects 0.000 claims description 17
- 229960002897 heparin Drugs 0.000 claims description 16
- 229920000669 heparin Polymers 0.000 claims description 16
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 15
- 230000005856 abnormality Effects 0.000 claims description 8
- 238000009434 installation Methods 0.000 claims 2
- 208000010718 Multiple Organ Failure Diseases 0.000 abstract description 45
- 239000003053 toxin Substances 0.000 abstract description 24
- 231100000765 toxin Toxicity 0.000 abstract description 24
- 108010088751 Albumins Proteins 0.000 abstract description 20
- 102000009027 Albumins Human genes 0.000 abstract description 20
- 150000003384 small molecules Chemical class 0.000 abstract description 12
- 238000000034 method Methods 0.000 abstract description 11
- 238000011282 treatment Methods 0.000 abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 9
- 239000000463 material Substances 0.000 abstract description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 abstract description 6
- 206010061218 Inflammation Diseases 0.000 abstract description 6
- 230000004054 inflammatory process Effects 0.000 abstract description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract description 5
- 239000001301 oxygen Substances 0.000 abstract description 5
- 229910052760 oxygen Inorganic materials 0.000 abstract description 5
- 210000004185 liver Anatomy 0.000 abstract description 4
- 229910021529 ammonia Inorganic materials 0.000 abstract description 3
- 210000003734 kidney Anatomy 0.000 abstract description 3
- 210000000056 organ Anatomy 0.000 abstract description 3
- 102000004169 proteins and genes Human genes 0.000 abstract description 3
- 108090000623 proteins and genes Proteins 0.000 abstract description 3
- 238000000746 purification Methods 0.000 abstract description 3
- 210000002216 heart Anatomy 0.000 abstract description 2
- 208000016253 exhaustion Diseases 0.000 abstract 2
- 208000024891 symptom Diseases 0.000 abstract 1
- 210000002381 plasma Anatomy 0.000 description 51
- 239000007788 liquid Substances 0.000 description 46
- 208000029744 multiple organ dysfunction syndrome Diseases 0.000 description 44
- 239000000243 solution Substances 0.000 description 27
- 108700012359 toxins Proteins 0.000 description 21
- 230000000694 effects Effects 0.000 description 19
- 230000004087 circulation Effects 0.000 description 18
- 239000000385 dialysis solution Substances 0.000 description 15
- 238000006073 displacement reaction Methods 0.000 description 13
- 230000002757 inflammatory effect Effects 0.000 description 10
- 238000012544 monitoring process Methods 0.000 description 10
- 230000008569 process Effects 0.000 description 10
- 206010051379 Systemic Inflammatory Response Syndrome Diseases 0.000 description 8
- 239000002158 endotoxin Substances 0.000 description 8
- 238000010521 absorption reaction Methods 0.000 description 7
- 238000001802 infusion Methods 0.000 description 7
- 238000002560 therapeutic procedure Methods 0.000 description 7
- 102000004127 Cytokines Human genes 0.000 description 5
- 108090000695 Cytokines Proteins 0.000 description 5
- 208000001647 Renal Insufficiency Diseases 0.000 description 5
- 230000002159 abnormal effect Effects 0.000 description 5
- 201000006370 kidney failure Diseases 0.000 description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 230000018044 dehydration Effects 0.000 description 4
- 238000006297 dehydration reaction Methods 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 206010019663 Hepatic failure Diseases 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 230000023555 blood coagulation Effects 0.000 description 3
- 239000003792 electrolyte Substances 0.000 description 3
- 238000002615 hemofiltration Methods 0.000 description 3
- 208000007903 liver failure Diseases 0.000 description 3
- 231100000835 liver failure Toxicity 0.000 description 3
- 239000002207 metabolite Substances 0.000 description 3
- 238000001179 sorption measurement Methods 0.000 description 3
- 230000007306 turnover Effects 0.000 description 3
- 206010014418 Electrolyte imbalance Diseases 0.000 description 2
- 206010019280 Heart failures Diseases 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- 208000034486 Multi-organ failure Diseases 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 230000000004 hemodynamic effect Effects 0.000 description 2
- 230000013632 homeostatic process Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 230000004768 organ dysfunction Effects 0.000 description 2
- 230000003204 osmotic effect Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 230000002685 pulmonary effect Effects 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 201000004193 respiratory failure Diseases 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 1
- 208000007788 Acute Liver Failure Diseases 0.000 description 1
- 206010000804 Acute hepatic failure Diseases 0.000 description 1
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 239000004380 Cholic acid Substances 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010053159 Organ failure Diseases 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- 208000004756 Respiratory Insufficiency Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 206010001053 acute respiratory failure Diseases 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- BPYKTIZUTYGOLE-UHFFFAOYSA-N billirubin-IXalpha Natural products N1C(=O)C(C)=C(C=C)C1=CC1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(C=C3C(=C(C=C)C(=O)N3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
- 229960002471 cholic acid Drugs 0.000 description 1
- 235000019416 cholic acid Nutrition 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 208000035850 clinical syndrome Diseases 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 125000004122 cyclic group Chemical class 0.000 description 1
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 208000028208 end stage renal disease Diseases 0.000 description 1
- 201000000523 end stage renal failure Diseases 0.000 description 1
- 231100000284 endotoxic Toxicity 0.000 description 1
- 230000002346 endotoxic effect Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 210000004276 hyalin Anatomy 0.000 description 1
- 208000018875 hypoxemia Diseases 0.000 description 1
- 230000001524 infective effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 238000002616 plasmapheresis Methods 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000002195 soluble material Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- 239000002912 waste gas Substances 0.000 description 1
Images
Landscapes
- External Artificial Organs (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200710078431XA CN100486651C (zh) | 2007-04-27 | 2007-04-27 | 多器官功能支持系统 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200710078431XA CN100486651C (zh) | 2007-04-27 | 2007-04-27 | 多器官功能支持系统 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101041092A CN101041092A (zh) | 2007-09-26 |
CN100486651C true CN100486651C (zh) | 2009-05-13 |
Family
ID=38807021
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB200710078431XA Active CN100486651C (zh) | 2007-04-27 | 2007-04-27 | 多器官功能支持系统 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100486651C (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102500003A (zh) * | 2011-11-30 | 2012-06-20 | 虞文魁 | 多功能体外生命支持与治疗系统一体化装置 |
WO2022123575A1 (en) | 2020-12-10 | 2022-06-16 | Plas-Free Ltd | Extracorporeal device and matrix for removing ammonia from biological fluids, methods and uses thereof |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102009037015A1 (de) * | 2009-08-07 | 2011-02-17 | Michael Hajek | Vorrichtung und Verfahren zur Eliminierung von bioschädlichen Stoffen aus Körperflüssigkeiten |
EP2679257B1 (en) * | 2011-02-23 | 2018-10-17 | Asahi Kasei Medical Co., Ltd. | Blood purification device |
EP2730303B1 (en) * | 2012-11-08 | 2015-08-12 | Gambro Lundia AB | Albumin pump control in a MARS treatment apparatus |
CN103251996B (zh) * | 2013-04-02 | 2015-09-30 | 周春华 | 便携式多器官功能支持一体化治疗机 |
CN105879137A (zh) * | 2014-09-15 | 2016-08-24 | 彭罗民 | 生命激活仪 |
CN104800902B (zh) * | 2015-04-30 | 2017-02-22 | 北京迈淩医疗技术发展有限公司 | 用于救治多器官功能衰竭的体外循环生命支持设备 |
CN105214154A (zh) * | 2015-08-07 | 2016-01-06 | 李淑秀 | 双滤式血液净化透析装置 |
TWI595897B (zh) * | 2016-03-31 | 2017-08-21 | 禾研科技股份有限公司 | 血液淨化系統 |
CN105879138B (zh) * | 2016-06-11 | 2018-12-28 | 赵晓玲 | 可切换血液分离器的血浆置换装置体外循环管路 |
DE102016125818A1 (de) * | 2016-12-28 | 2018-06-28 | I3 Membrane Gmbh | Verfahren zur Separation von geladenen biologisch aktiven Substanzen aus Flüssigkeiten und deren Wiedergewinnung |
CN109045379A (zh) * | 2018-07-12 | 2018-12-21 | 安陆恩彼饲料有限公司 | 一种血浆净化方法 |
CN111603628B (zh) * | 2020-07-17 | 2024-09-03 | 刘燕 | 一种心脏手术体外循环用贮血装置 |
CN114907972A (zh) * | 2021-02-09 | 2022-08-16 | 苏州心擎医疗技术有限公司 | 多器官体外生命支持系统 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5277820A (en) * | 1992-02-06 | 1994-01-11 | Hemocleanse, Inc. | Device and method for extracorporeal blood treatment |
CN1190598A (zh) * | 1997-09-30 | 1998-08-19 | 彭罗民 | 生命支持仪 |
CN201026322Y (zh) * | 2007-04-28 | 2008-02-27 | 高光勇 | 一种多器官功能支持系统 |
-
2007
- 2007-04-27 CN CNB200710078431XA patent/CN100486651C/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5277820A (en) * | 1992-02-06 | 1994-01-11 | Hemocleanse, Inc. | Device and method for extracorporeal blood treatment |
CN1190598A (zh) * | 1997-09-30 | 1998-08-19 | 彭罗民 | 生命支持仪 |
CN201026322Y (zh) * | 2007-04-28 | 2008-02-27 | 高光勇 | 一种多器官功能支持系统 |
Non-Patent Citations (4)
Title |
---|
多脏器功能不全综合征体外支持治疗进展. 贾丽芳.中国血液净化,第5卷第6期. 2006 |
多脏器功能不全综合征体外支持治疗进展. 贾丽芳.中国血液净化,第5卷第6期. 2006 * |
多脏器功能衰竭体外生命支持系统的进展. 王质刚.中华肾脏病杂志,第22卷第3期. 2006 |
多脏器功能衰竭体外生命支持系统的进展. 王质刚.中华肾脏病杂志,第22卷第3期. 2006 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102500003A (zh) * | 2011-11-30 | 2012-06-20 | 虞文魁 | 多功能体外生命支持与治疗系统一体化装置 |
WO2022123575A1 (en) | 2020-12-10 | 2022-06-16 | Plas-Free Ltd | Extracorporeal device and matrix for removing ammonia from biological fluids, methods and uses thereof |
Also Published As
Publication number | Publication date |
---|---|
CN101041092A (zh) | 2007-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100486651C (zh) | 多器官功能支持系统 | |
US11786645B2 (en) | Fluid circuit for delivery of renal replacement therapies | |
CN105025951B (zh) | 用于多功能体积流体控制的系统和方法 | |
CN105120913B (zh) | 用于模块化受控相容流路的钠和缓冲液源盒 | |
CN100460026C (zh) | 医用血液透析滤过机 | |
US10857277B2 (en) | Modular hemodialysis system | |
CN201026321Y (zh) | 一种人工肝肾支持系统 | |
US20180353668A1 (en) | Modular fluid therapy system having jumpered flow paths and systems and methods for cleaning and disinfection | |
KR102211104B1 (ko) | 혈액투석여과장치 | |
EP2739325B1 (en) | Hemodialysis system having a flow path with a controlled compliant volume | |
CN1071585C (zh) | 血液过滤和血浆过滤的装置和方法 | |
CN100493633C (zh) | 人工肝肾支持系统 | |
CN102389594B (zh) | 便携式血液净化系统 | |
CN101269246B (zh) | 一种带置换液净化器的连续血液净化设备 | |
CN2905076Y (zh) | 血液透析滤过机 | |
CN107583120A (zh) | 一种血浆置换透析吸附系统 | |
CN209900240U (zh) | 佩戴式滤过型人工肾装置 | |
CN106344985B (zh) | 一种多功能再生血液净化系统 | |
CN201026322Y (zh) | 一种多器官功能支持系统 | |
CN201186074Y (zh) | 带置换液净化器的连续血液净化设备 | |
JP4129726B2 (ja) | 腹膜透析装置 | |
CN203619966U (zh) | 血液透析滤过联合腹水超滤回输的血液腹水净化装置 | |
CN101987210B (zh) | 血液滤过系统 | |
CN203677608U (zh) | 采用crrt机进行血液净化联合腹水超滤回输的装置 | |
CN208552666U (zh) | 一种血浆置换透析吸附系统 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Multiple organ dysfunction and support system Effective date of registration: 20120802 Granted publication date: 20090513 Pledgee: Chongqing Sanxia bank Limited by Share Ltd New District Branch Pledgor: Gao Guangyong|Chongqing Shanwaishan science and Technology Co Ltd Registration number: 2012990000422 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20130820 Granted publication date: 20090513 Pledgee: Chongqing Sanxia bank Limited by Share Ltd New District Branch Pledgor: Gao Guangyong|Chongqing Shanwaishan science and Technology Co Ltd Registration number: 2012990000422 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Multiple organ dysfunction and support system Effective date of registration: 20130820 Granted publication date: 20090513 Pledgee: Chongqing Sanxia bank Limited by Share Ltd New District Branch Pledgor: Gao Guangyong|Chongqing Shanwaishan science and Technology Co Ltd Registration number: 2013990000593 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20150203 Granted publication date: 20090513 Pledgee: Chongqing Sanxia bank Limited by Share Ltd New District Branch Pledgor: Gao Guangyong|Chongqing Shanwaishan science and Technology Co Ltd Registration number: 2013990000593 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Multiple organ dysfunction and support system Effective date of registration: 20150205 Granted publication date: 20090513 Pledgee: Chongqing Sanxia bank Limited by Share Ltd New District Branch Pledgor: Gao Guangyong|Chongqing Shanwaishan science and Technology Co Ltd Registration number: 2015990000104 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160106 Address after: Plant south block B No. 5 building, 401121 mercury technology in Chongqing city in northern New Mount Huangshan Avenue Patentee after: Chongqing Shanwaishan Science & Technology Co., Ltd. Address before: 400050 Avenue in Chongqing City Jiulongpo straight port No. 199 Pearl River Garden 27 3 unit 8-4 Patentee before: Gao Guangyong |
|
C56 | Change in the name or address of the patentee | ||
CB03 | Change of inventor or designer information |
Inventor after: Gao Guangyong Inventor after: Ren Yingxiang Inventor before: Lin Jinchao Inventor before: Gao Guangyong Inventor before: Ren Yingxiang |
|
COR | Change of bibliographic data | ||
CP03 | Change of name, title or address |
Address after: The 401121 northern New District of Chongqing municipality Mount Huangshan Road No. 5 South Building Mercury Technology Development Center Patentee after: SWS HEMODIALSIS CARE CO., LTD. Address before: Plant south block B No. 5 building, 401121 mercury technology in Chongqing city in northern New Mount Huangshan Avenue Patentee before: Chongqing Shanwaishan Science & Technology Co., Ltd. |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20160531 Granted publication date: 20090513 Pledgee: Chongqing Sanxia bank Limited by Share Ltd New District Branch Pledgor: SWS HEMODIALSIS CARE CO., LTD. Registration number: 2015990000104 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PM01 | Change of the registration of the contract for pledge of patent right |
Change date: 20160531 Registration number: 2015990000104 Pledgor after: Chongqing Shanwaishan Science & Technology Co., Ltd. Pledgor before: Gao Guangyong Pledgor before: Chongqing Shanwaishan science and Technology Co Ltd |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Multiple organ dysfunction and support system Effective date of registration: 20170310 Granted publication date: 20090513 Pledgee: Export Import Bank of China Pledgor: SWS HEMODIALSIS CARE CO., LTD. Registration number: 2017980000035 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
CP02 | Change in the address of a patent holder |
Address after: 401123 Tzu Chi Road, Liangjiang New Area, Chongqing, No. 1 Patentee after: SWS HEMODIALSIS CARE CO., LTD. Address before: The 401121 northern New District of Chongqing municipality Mount Huangshan Road No. 5 South Building Mercury Technology Development Center Patentee before: SWS HEMODIALSIS CARE CO., LTD. |
|
CP02 | Change in the address of a patent holder | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20210129 Granted publication date: 20090513 Pledgee: Export Import Bank of China Pledgor: SWS HEMODIALYSIS CARE Co.,Ltd. Registration number: 2017980000035 |